Standout Papers

Dasatinib versus Imatinib in Newly Diagnosed Chronic-Phase Chronic Myeloid Leukemia 2010 2026 2015 2020 1.1k
  1. Dasatinib versus Imatinib in Newly Diagnosed Chronic-Phase Chronic Myeloid Leukemia (2010)
    Hagop M. Kantarjian, Neil P. Shah et al. New England Journal of Medicine
  2. Final 5-Year Study Results of DASISION: The Dasatinib Versus Imatinib Study in Treatment-Naïve Chronic Myeloid Leukemia Patients Trial (2016)
    Jörge E. Cortes, Giuseppe Saglio et al. Journal of Clinical Oncology

Immediate Impact

11 from Science/Nature 65 standout
Sub-graph 1 of 20

Citing Papers

Principles and therapeutic applications of adaptive immunity
2024 Standout
Cancer biomarkers: Emerging trends and clinical implications for personalized treatment
2024 Standout
23 intermediate papers

Works of Concepción Boqué being referenced

Final 5-Year Study Results of DASISION: The Dasatinib Versus Imatinib Study in Treatment-Naïve Chronic Myeloid Leukemia Patients Trial
2016 Standout
Dasatinib versus Imatinib in Newly Diagnosed Chronic-Phase Chronic Myeloid Leukemia
2010 Standout
and 1 more

Author Peers

Author Last Decade Papers Cites
Concepción Boqué 1598 1946 1006 23 2.2k
M. Brigid Bradley‐Garelik 1832 2186 1207 27 2.4k
Beatriz Moiraghi 1504 1762 1000 41 2.0k
Chao Zhu 1496 1788 1009 48 2.2k
Albert Hoenekopp 1309 1574 836 21 1.8k
Athena Countouriotis 1391 1607 924 21 1.9k
Philippe Rousselot 1621 1977 984 31 2.2k
Philipp D. le Coutre 1850 2178 1190 72 2.4k
Franck E. Nicolini 2053 2610 1195 56 2.9k
Ron Paquette 1133 1716 614 23 2.2k
Michele Baccarani 1400 1555 884 22 2.0k

All Works

Loading papers...

Rankless by CCL
2026